Secondary Metabolites Produced by the Marine Bacterium Halobacillus salinus That Inhibit Quorum Sensing-Controlled Phenotypes in Gram-Negative Bacteria

Certain bacteria use cell-to-cell chemical communication to coordinate community-wide phenotypic expression, including swarming motility, antibiotic biosynthesis, and biofilm production. Here we present a marine gram-positive bacterium that secretes secondary metabolites capable of quenching quorum...

Full description

Saved in:
Bibliographic Details
Published inApplied and Environmental Microbiology Vol. 75; no. 3; pp. 567 - 572
Main Authors Teasdale, Margaret E, Liu, Jiayuan, Wallace, Joselynn, Akhlaghi, Fatemeh, Rowley, David C
Format Journal Article
LanguageEnglish
Published Washington, DC American Society for Microbiology 01.02.2009
American Society for Microbiology (ASM)
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Certain bacteria use cell-to-cell chemical communication to coordinate community-wide phenotypic expression, including swarming motility, antibiotic biosynthesis, and biofilm production. Here we present a marine gram-positive bacterium that secretes secondary metabolites capable of quenching quorum sensing-controlled behaviors in several gram-negative reporter strains. Isolate C42, a Halobacillus salinus strain obtained from a sea grass sample, inhibits bioluminescence production by Vibrio harveyi in cocultivation experiments. With the use of bioassay-guided fractionation, two phenethylamide metabolites were identified as the active agents. The compounds additionally inhibit quorum sensing-regulated violacein biosynthesis by Chromobacterium violaceum CV026 and green fluorescent protein production by Escherichia coli JB525. Bacterial growth was unaffected at concentrations below 200 μg/ml. Evidence is presented that these nontoxic metabolites may act as antagonists of bacterial quorum sensing by competing with N-acyl homoserine lactones for receptor binding.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
Corresponding author. Mailing address: University of Rhode Island, Department of Biomedical and Pharmaceutical Sciences, 53 Fogarty Hall, Kingston, RI 02881. Phone: (401) 874-9228. Fax: (401) 874-5787. E-mail: drowley@uri.edu
ISSN:0099-2240
1098-5336
1098-6596
DOI:10.1128/AEM.00632-08